Cipla
Sushil Kale is an experienced professional in the pharmaceutical industry with a career spanning over two decades. Currently serving as the National Sales Head and Director for Respiratory Orals at Cipla since April 2019, Sushil has held various leadership roles including Director of Marketing and Division Sales Head for Respiratory (ILD & PH). Prior to Cipla, Sushil worked at USV Private Limited as Marketing Manager and Group Product Manager, and at Macleods Pharmaceuticals Ltd. in multiple product management roles. Early in the career, Sushil gained experience at Khandelwal Laboratories, Meyer Organics, GSK, and Ranbaxy, starting as a Medical Representative. Sushil holds a Master of Business Administration in Marketing from Symbiosis Institute of Management Studies.
This person is not in the org chart
This person is not in any teams
Cipla
19 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.